
Thu, Aug 27, 2026 2:00 PM EDT (11:30 PM Asia/Calcutta)
Event Overview:
Mid-size and emerging pharma companies face the same enrollment pressures as large pharma but must navigate them with fewer resources, less historical data, and limited room for error. As a result, every country selection, site recommendation, and enrollment assumption carries outsized impact on study timelines, costs, and development milestone achievement.
This webinar explores how clinical development and operations teams can make more confident country and site selection decisions, even when working with imperfect evidence and lean teams. The session will demonstrate how data-driven forecasting can improve planning confidence while reducing reliance solely on CRO insights and experience-driven inputs. It will also examine how continuous monitoring, early warning signals, and dynamic reforecasting can help identify risks sooner, enable faster intervention, and drive more predictable trial execution.
Key Learning Objectives:
Who Should Attend:
This webcast is designed for professionals involved in clinical trial planning, feasibility, and operational strategy, including:
Featured Speakers:

Director, Products
ZS Associates
Harini Lakshminarayanan is a product leader for ZS's ZAIDYN® Clinical platform, driving study planning. With 15-plus years of experience across biopharma R&D and clinical operations, she helps life sciences clients turn complex data into smarter decisions by translating deep clinical expertise into products that accelerate drug development.
Speaker's Email: Harini.Lakshminarayanan@zs.com
Speaker's LinkedIn: Harini Lakshminarayanan

Principal
ZS Associates
Jennifer Baltzell is a principal at ZS who helps pharmaceutical and biotechnology companies transform how they plan and execute clinical development. With more than 20 years of experience leading large-scale business and digital transformation initiatives across the life sciences industry, she now focuses on applying AI, advanced analytics, and innovative operating models to improve study planning, enrollment forecasting, clinical operations, and trial performance.
Speaker's Email: jennifer.baltzell@zs.com

GM, ZAIDYN Clinical
ZS Associates
Maria Kliatchko leads ZAIDYN® Clinical at ZS, helping life sciences organizations apply AI, analytics, and technology to improve clinical development planning and decision-making. With more than 25 years of experience across pharmaceutical, medical device, and healthcare organizations, she has advised clients on advancing analytics capabilities, building data-driven operating models, and improving outcomes through innovative analytics and data science.
Speaker's Email: maria.kliatchko@zs.com
Speaker's LinkedIn: Maria Kliatchko
Complete this form to enter the webcast.
(* indicates required field)